| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000015959 |
| Receipt No. | R000018530 |
| Official scientific title of the study | A study of clinical usefulness and safety of enteral nutrition containing pectin. |
| Date of disclosure of the study information | 2015/02/12 |
| Last modified on | 2017/06/19 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | A study of clinical usefulness and safety of enteral nutrition containing pectin. | |
| Title of the study (Brief title) | A study of clinical usefulness and safety of enteral nutrition containing pectin. | |
| Region |
|
|
| Condition | ||||
| Condition | Patients on nasoeal feeding | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | A study of clinical usefulness and safety of enteral nutrition containing pectin. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Completion rate of nutrition mamagement |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Patients are taken enteral nutrition containing pectin for 7 days | ||
| Interventions/Control_2 | Patients are taken nomal enteral nutrition for 7 days | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients on tube feeding, not oral intake
2.Patients on NG tube 3.Patients taking on tube feeding only 4.Patients taken more than half of the planned adminitration amount of energy the day before 5.Patients taken enteral nutrition for a week or more after the start of this study 6.Patients informed consent |
|||
| Key exclusion criteria | 1.Patients with diarrhea the day before
2.Patients treated with the disable drug and REF-P1 3.Patients undergone with total or subtotal gastrectomy 4.Patients treated with the chemotherapy 5.Patients with the ileus 6.Patients with electrolyte imbalance 7.Patients with severe liver dysfunction or severe kidney dysfunction 8.Patiens with glucose metabolism disorder such as diabetes or inborn error of amino acid metabolism 9.Patients with infectious enteritis 10.Patients with other conditions not suitable for this study |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Michio Maruyama |
| Organization | Japan Society for Parenteral and Enteral Nutiroin |
| Division name | Clinical Nutrition Working Committee |
| Address | Shiba-Daimon116bdlg 3F-B 1-16-3 Shiba-Daimon Minato-ku Tokyo Japan |
| TEL | 03-5777-2314 |
| jspen2@jspen.jp | |
| Public contact | |
| Name of contact person | Michio Maruyama |
| Organization | Japan Society for Parenteral and Enteral Nutiroin |
| Division name | Clinical Nutrition Working Committee |
| Address | Shiba-Daimon116bdlg 3F-B 1-16-3 Shiba-Daimon Minato-ku Tokyo Japan |
| TEL | 03-5777-2314 |
| Homepage URL | |
| jspen2@jspen.jp | |
| Sponsor | |
| Institute | Japan Society for Parenteral and Enteral Nutiroin |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Otsuka Pharmaceutical Factory, Inc |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018530 |